EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Novel Cytochrome P450-3A4 Enzymatic Nanobiosensor for Lapatinib (a Breast Cancer Drug) Developed on a Poly(anilino-co-4-aminobenzoic Acid-Green-Synthesised Indium Nanoparticle) Platform

Jaymi Leigh January iD, Ziyanda Zamaswazi Tshobeni, Nokwanda Precious Pearl Ngema, Abongile Nwabisa Jijana iD, Emmanuel Iheanyichukwu Iwuoha iD, Takalani Mulaudzi iD, Samantha Fiona Douman, Rachel Fanelwa Ajayi iD

Biosensors · 21.09.2023 · 13 (9) · 897

DOI: 10.3390/bios13090897 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biosensors, online erschienen am 21.09.2023. Verfasst von Jaymi Leigh January und 7 weiteren Autor:innen. Beteiligte Einrichtung: SensorLab (UWC Sensor Laboratories), University of the Western Cape, Private Bag X17, Bellville, Cape Town 7535, South Africa. Hauptthemen laut MEDLINE: Breast Neoplasms, Antineoplastic Agents, Nanoparticles, Biosensing Techniques. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 127 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Nanoscience Postgraduate Teaching and Training Platform, the South African Department of Science and Innovation (DSI).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer (BC) is one of the most common types of cancer disease worldwide and it accounts for thousands of deaths annually. Lapatinib is among the preferred drugs for the treatment of breast cancer. Possible drug toxicity effects of lapatinib can be controlled by real-time determination of the appropriate dose for a patient at the point of care. In this study, a novel highly sensitive polymeric nanobiosensor for lapatinib is presented. A composite of poly(anilino-co-4-aminobenzoic acid) co-polymer {poly(ANI-co-4-ABA)} and coffee extract-based green-synthesized indium nanoparticles (InNPs) was used to develop the sensor platform on a screen-printed carbon electrode (SPCE), i.e., SPCE||poly(ANI-co-4-ABA-InNPs). Cytochrome P450-3A4 (CYP3A4) enzyme and polyethylene glycol (PEG) were incorporated on the modified platform to produce the SPCE||poly(ANI-co-4-ABA-InNPs)|CYP3A4|PEG lapatinib nanobiosensor. Experiments for the determination of the electrochemical response characteristics of the nanobiosensor were performed with cyclic voltammetry (CV) and differential pulse voltammetry (DPV). The nanobiosensor calibration for 0–100 ng/mL lapatinib was linear and gave limit of detection (LOD) values of 13.21 ng/mL lapatinib and 18.6 ng/mL lapatinib in physiological buffer and human serum, respectively. The LOD values are much lower than the peak plasma concentration (Cmax) of lapatinib (2.43 µg/mL), which is attained 4 h after the administration of a daily dose of 1250 mg lapatinib. The electrochemical nanobiosensor also exhibited excellent anti-interference performance and stability.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsAntineoplastic AgentsNanoparticlesBiosensing TechniquesHumansFemaleLapatinib4-Aminobenzoic AcidIndiumPharmaceutical PreparationsCytochrome P-450 CYP3AElectrodesElectrochemical TechniquesAnthracenes

Stichwörter der Autor:innen

biosensorbreast cancer drug (lapatinib)cytochrome P450-3A4green-synthesized indium nanoparticlespolyaniline

Substanzen

Lapatinib4-Aminobenzoic AcidIndiumPharmaceutical PreparationsCytochrome P-450 CYP3AAntineoplastic Agents4-(2-anthryl)butanoic acidAnthracenes

Autor:innen und Institutionen

  • SensorLab (UWC Sensor Laboratories), University of the Western Cape, Private Bag X17, Bellville, Cape Town 7535, South Africa.
  • Nanotechnology Innovation Centre, Advanced Materials Division, Mintek, Private Bag X3015, Randburg, Johannesburg 2125, South Africa.
  • Department of Biotechnology, University of the Western Cape, Private Bag X17, Bellville, Cape Town 7535, South Africa.
  • Department of Chemistry, University of Cape Town, Private Bag X3, Rondebosch, Cape Town 7701, South Africa.

ORCID-Profile: Jaymi Leigh January, Abongile Nwabisa Jijana, Emmanuel Iheanyichukwu Iwuoha, Takalani Mulaudzi, Rachel Fanelwa Ajayi

Förderung

  • National Nanoscience Postgraduate Teaching and Training Platform
  • the South African Department of Science and Innovation (DSI)

Zitieren

APA

January, J. L., Tshobeni, Z. Z., Ngema, N. P. P., Jijana, A. N., Iwuoha, E. I., Mulaudzi, T., Douman, S. F., & Ajayi, R. F. (2023). Novel Cytochrome P450-3A4 Enzymatic Nanobiosensor for Lapatinib (a Breast Cancer Drug) Developed on a Poly(anilino-co-4-aminobenzoic Acid-Green-Synthesised Indium Nanoparticle) Platform. Biosensors, 13(9), 897. https://doi.org/10.3390/bios13090897

Vancouver

January JL, Tshobeni ZZ, Ngema NPP, Jijana AN, Iwuoha EI, Mulaudzi T, et al. Novel Cytochrome P450-3A4 Enzymatic Nanobiosensor for Lapatinib (a Breast Cancer Drug) Developed on a Poly(anilino-co-4-aminobenzoic Acid-Green-Synthesised Indium Nanoparticle) Platform. Biosensors. 2023;13(9):897. doi:10.3390/bios13090897

BibTeX
@article{January2023,
  author = {January, Jaymi Leigh and Tshobeni, Ziyanda Zamaswazi and Ngema, Nokwanda Precious Pearl and Jijana, Abongile Nwabisa and Iwuoha, Emmanuel Iheanyichukwu and Mulaudzi, Takalani and Douman, Samantha Fiona and Ajayi, Rachel Fanelwa},
  title = {Novel Cytochrome P450-3A4 Enzymatic Nanobiosensor for Lapatinib (a Breast Cancer Drug) Developed on a Poly(anilino-co-4-aminobenzoic Acid-Green-Synthesised Indium Nanoparticle) Platform},
  journal = {Biosensors},
  year = {2023},
  volume = {13},
  number = {9},
  pages = {897},
  doi = {10.3390/bios13090897}
}
Kostenlos starten →